Do analysts rate AIFF or AISP?

Airship AI has a consensus target price of $6.50, indicating a potential upside of 124.14%. Given Airship AI's higher possible upside, analysts plainly believe Airship AI is more favorable than Firefly Neuroscience. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Airship AI 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to AIFF or AISP?

In the previous week, Firefly Neuroscience and Firefly Neuroscience both had 2 articles in the media. Firefly Neuroscience's average media sentiment score of 0.94 beat Airship AI's score of 0.93 indicating that Firefly Neuroscience is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Firefly Neuroscience 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Airship AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend AIFF or CCLD?

CareCloud has a consensus target price of $3.25, indicating a potential upside of 41.92%. Given CareCloud's stronger consensus rating and higher possible upside, analysts clearly believe CareCloud is more favorable than Firefly Neuroscience. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 CareCloud 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media favor AIFF or CCLD?

In the previous week, CareCloud had 2 more articles in the media than Firefly Neuroscience. MarketBeat recorded 4 mentions for CareCloud and 2 mentions for Firefly Neuroscience. CareCloud's average media sentiment score of 0.97 beat Firefly Neuroscience's score of 0.94 indicating that CareCloud is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Firefly Neuroscience 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CareCloud 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend TEAD or AIFF?

Teads presently has a consensus price target of $3.27, suggesting a potential upside of 163.44%. Given Teads' stronger consensus rating and higher possible upside, analysts clearly believe Teads is more favorable than Firefly Neuroscience. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teads 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer TEAD or AIFF?

In the previous week, Teads had 2 more articles in the media than Firefly Neuroscience. MarketBeat recorded 4 mentions for Teads and 2 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 0.94 beat Teads' score of 0.76 indicating that Firefly Neuroscience is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teads 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Firefly Neuroscience 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend AIFF or AEYE?

Audioeye has a consensus target price of $14.63, suggesting a potential upside of 118.94%. Given Audioeye's stronger consensus rating and higher possible upside, analysts clearly believe Audioeye is more favorable than Firefly Neuroscience. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Audioeye 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50

Does the media prefer AIFF or AEYE?

In the previous week, Audioeye had 1 more articles in the media than Firefly Neuroscience. MarketBeat recorded 3 mentions for Audioeye and 2 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 0.94 beat Audioeye's score of 0.91 indicating that Firefly Neuroscience is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Firefly Neuroscience 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Audioeye 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend AIFF or DH?

Definitive Healthcare has a consensus target price of $2.77, suggesting a potential upside of 232.73%. Given Definitive Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Definitive Healthcare is more favorable than Firefly Neuroscience. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Definitive Healthcare 3 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.00

Does the media favor AIFF or DH?

In the previous week, Definitive Healthcare had 1 more articles in the media than Firefly Neuroscience. MarketBeat recorded 3 mentions for Definitive Healthcare and 2 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 0.94 beat Definitive Healthcare's score of 0.31 indicating that Firefly Neuroscience is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Firefly Neuroscience 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Definitive Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Firefly Neuroscience (AIFF) Competitors

$1.60 -0.01 (-0.62%)

Closing price 04:00 PM Eastern

Extended Trading

$1.57 -0.03 (-1.63%)

As of 07:51 PM Eastern

Compare

AIFF vs. AISP, CCLD, TEAD, AEYE, and DH

Should you buy Firefly Neuroscience stock or one of its competitors? MarketBeat compares Firefly Neuroscience with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Firefly Neuroscience include Airship AI (AISP), CareCloud (CCLD), Teads (TEAD), Audioeye (AEYE), and Definitive Healthcare (DH). These companies are all part of the "computer software" industry.

How does Firefly Neuroscience compare to Airship AI?

Firefly Neuroscience (NASDAQ:AIFF) and Airship AI (NASDAQ:AISP) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Firefly Neuroscience has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, Airship AI has a beta of 0.5, suggesting that its share price is 50% less volatile than the broader market.

In the previous week, Firefly Neuroscience and Firefly Neuroscience both had 2 articles in the media. Firefly Neuroscience's average media sentiment score of 0.94 beat Airship AI's score of 0.93 indicating that Firefly Neuroscience is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Firefly Neuroscience	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Airship AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Airship AI has higher revenue and earnings than Firefly Neuroscience. Airship AI is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$1.14M	21.85	-$19.88M	-$0.63	N/A
Airship AI	$16.17M	6.18	$29.32M	-$0.01	N/A

Airship AI has a consensus target price of $6.50, indicating a potential upside of 124.14%. Given Airship AI's higher possible upside, analysts plainly believe Airship AI is more favorable than Firefly Neuroscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Airship AI	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Airship AI has a net margin of 30.26% compared to Firefly Neuroscience's net margin of -565.40%. Airship AI's return on equity of 0.00% beat Firefly Neuroscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-565.40%	-94.68%	-73.51%
Airship AI	30.26%	N/A	-136.39%

5.0% of Firefly Neuroscience shares are owned by institutional investors. Comparatively, 5.9% of Airship AI shares are owned by institutional investors. 6.4% of Firefly Neuroscience shares are owned by insiders. Comparatively, 46.8% of Airship AI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Airship AI beats Firefly Neuroscience on 8 of the 13 factors compared between the two stocks.

How does Firefly Neuroscience compare to CareCloud?

Firefly Neuroscience (NASDAQ:AIFF) and CareCloud (NASDAQ:CCLD) are both small-cap computer software companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.

CareCloud has a consensus target price of $3.25, indicating a potential upside of 41.92%. Given CareCloud's stronger consensus rating and higher possible upside, analysts clearly believe CareCloud is more favorable than Firefly Neuroscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, CareCloud had 2 more articles in the media than Firefly Neuroscience. MarketBeat recorded 4 mentions for CareCloud and 2 mentions for Firefly Neuroscience. CareCloud's average media sentiment score of 0.97 beat Firefly Neuroscience's score of 0.94 indicating that CareCloud is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Firefly Neuroscience	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CareCloud	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

5.0% of Firefly Neuroscience shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 6.4% of Firefly Neuroscience shares are owned by company insiders. Comparatively, 14.8% of CareCloud shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Firefly Neuroscience has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market. Comparatively, CareCloud has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market.

CareCloud has a net margin of 7.87% compared to Firefly Neuroscience's net margin of -565.40%. CareCloud's return on equity of 24.05% beat Firefly Neuroscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-565.40%	-94.68%	-73.51%
CareCloud	7.87%	24.05%	16.38%

CareCloud has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$1.14M	21.85	-$19.88M	-$0.63	N/A
CareCloud	$120.50M	0.81	$10.80M	$0.11	20.82

Summary

CareCloud beats Firefly Neuroscience on 15 of the 16 factors compared between the two stocks.

How does Firefly Neuroscience compare to Teads?

Teads (NASDAQ:TEAD) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

In the previous week, Teads had 2 more articles in the media than Firefly Neuroscience. MarketBeat recorded 4 mentions for Teads and 2 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 0.94 beat Teads' score of 0.76 indicating that Firefly Neuroscience is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teads	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Firefly Neuroscience	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Teads has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

Firefly Neuroscience has lower revenue, but higher earnings than Teads. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Teads, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teads	$1.30B	0.09	-$517.07M	-$5.24	N/A
Firefly Neuroscience	$1.14M	21.85	-$19.88M	-$0.63	N/A

60.4% of Teads shares are held by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are held by institutional investors. 12.0% of Teads shares are held by insiders. Comparatively, 6.4% of Firefly Neuroscience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Teads presently has a consensus price target of $3.27, suggesting a potential upside of 163.44%. Given Teads' stronger consensus rating and higher possible upside, analysts clearly believe Teads is more favorable than Firefly Neuroscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teads	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Teads has a net margin of -39.14% compared to Firefly Neuroscience's net margin of -565.40%. Teads' return on equity of -17.58% beat Firefly Neuroscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teads	-39.14%	-17.58%	-3.50%
Firefly Neuroscience	-565.40%	-94.68%	-73.51%

Summary

Teads beats Firefly Neuroscience on 12 of the 16 factors compared between the two stocks.

How does Firefly Neuroscience compare to Audioeye?

Firefly Neuroscience (NASDAQ:AIFF) and Audioeye (NASDAQ:AEYE) are both small-cap computer software companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

Audioeye has a consensus target price of $14.63, suggesting a potential upside of 118.94%. Given Audioeye's stronger consensus rating and higher possible upside, analysts clearly believe Audioeye is more favorable than Firefly Neuroscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Audioeye	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

5.0% of Firefly Neuroscience shares are held by institutional investors. Comparatively, 51.1% of Audioeye shares are held by institutional investors. 6.4% of Firefly Neuroscience shares are held by company insiders. Comparatively, 25.9% of Audioeye shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Audioeye has a net margin of -9.05% compared to Firefly Neuroscience's net margin of -565.40%. Audioeye's return on equity of 71.24% beat Firefly Neuroscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-565.40%	-94.68%	-73.51%
Audioeye	-9.05%	71.24%	11.35%

In the previous week, Audioeye had 1 more articles in the media than Firefly Neuroscience. MarketBeat recorded 3 mentions for Audioeye and 2 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 0.94 beat Audioeye's score of 0.91 indicating that Firefly Neuroscience is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Firefly Neuroscience	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Audioeye	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Firefly Neuroscience has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, Audioeye has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market.

Audioeye has higher revenue and earnings than Firefly Neuroscience. Audioeye is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$1.14M	21.85	-$19.88M	-$0.63	N/A
Audioeye	$40.31M	2.07	-$3.08M	-$0.29	N/A

Summary

Audioeye beats Firefly Neuroscience on 13 of the 16 factors compared between the two stocks.

How does Firefly Neuroscience compare to Definitive Healthcare?

Firefly Neuroscience (NASDAQ:AIFF) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer software companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.

Firefly Neuroscience has higher earnings, but lower revenue than Definitive Healthcare. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$1.14M	21.85	-$19.88M	-$0.63	N/A
Definitive Healthcare	$241.52M	0.36	-$138.93M	-$1.62	N/A

In the previous week, Definitive Healthcare had 1 more articles in the media than Firefly Neuroscience. MarketBeat recorded 3 mentions for Definitive Healthcare and 2 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 0.94 beat Definitive Healthcare's score of 0.31 indicating that Firefly Neuroscience is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Firefly Neuroscience	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Definitive Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Firefly Neuroscience has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.33, suggesting that its share price is 33% more volatile than the broader market.

Definitive Healthcare has a net margin of -76.04% compared to Firefly Neuroscience's net margin of -565.40%. Definitive Healthcare's return on equity of 4.04% beat Firefly Neuroscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-565.40%	-94.68%	-73.51%
Definitive Healthcare	-76.04%	4.04%	1.99%

5.0% of Firefly Neuroscience shares are owned by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are owned by institutional investors. 6.4% of Firefly Neuroscience shares are owned by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Definitive Healthcare has a consensus target price of $2.77, suggesting a potential upside of 232.73%. Given Definitive Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Definitive Healthcare is more favorable than Firefly Neuroscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Definitive Healthcare	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00

Summary

Definitive Healthcare beats Firefly Neuroscience on 13 of the 17 factors compared between the two stocks.

Get Firefly Neuroscience News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIFF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AIFF vs. The Competition

Export

Metric	Firefly Neuroscience	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$25.07M	$3.96B	$6.59B	$11.95B
Dividend Yield	N/A	2.14%	3.10%	5.61%
P/E Ratio	-2.54	39.50	27.45	23.63
Price / Sales	21.85	45.30	398.31	103.49
Price / Cash	N/A	39.05	23.44	54.72
Price / Book	2.81	4.61	5.73	6.70
Net Income	-$19.88M	$31.68M	$202.45M	$337.26M
7 Day Performance	-3.03%	-5.61%	-1.77%	-1.41%
1 Month Performance	-15.34%	12.08%	5.74%	1.15%
1 Year Performance	-51.66%	16.99%	28.83%	22.61%

Firefly Neuroscience Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AIFF Firefly Neuroscience	0.6317 of 5 stars	$1.60 -0.6%	N/A	-50.6%	$25.07M	$1.14M	N/A	N/A	News Coverage Positive News
AISP Airship AI	2.8217 of 5 stars	$3.01 -4.7%	$6.50 +115.9%	-44.1%	$108.83M	$15.32M	N/A	47	News Coverage Positive News
CCLD CareCloud	4.3504 of 5 stars	$2.35 -4.5%	$3.25 +38.3%	+9.6%	$104.53M	$120.50M	21.37	3,650
TEAD Teads	2.5677 of 5 stars	$1.24 +15.3%	$3.13 +152.7%	N/A	$104.27M	$1.30B	N/A	1,700	Positive News Analyst Forecast Gap Up
AEYE Audioeye	3.6585 of 5 stars	$7.50 -8.3%	$14.63 +95.0%	-45.4%	$102.20M	$40.31M	N/A	110

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AIFF) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Firefly Neuroscience (AIFF) Competitors

AIFF vs. AISP, CCLD, TEAD, AEYE, and DH

How does Firefly Neuroscience compare to Airship AI?

Summary

How does Firefly Neuroscience compare to CareCloud?

Summary

How does Firefly Neuroscience compare to Teads?

Summary

How does Firefly Neuroscience compare to Audioeye?

Summary

How does Firefly Neuroscience compare to Definitive Healthcare?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIFF vs. The Competition

Firefly Neuroscience Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Firefly Neuroscience (AIFF) Competitors

AIFF vs. AISP, CCLD, TEAD, AEYE, and DH

How does Firefly Neuroscience compare to Airship AI?

Which has more volatility and risk, AIFF or AISP?

Does the media refer more to AIFF or AISP?

Which has better valuation and earnings, AIFF or AISP?

Do analysts rate AIFF or AISP?

Is AIFF or AISP more profitable?

Do insiders & institutionals believe in AIFF or AISP?

Summary

How does Firefly Neuroscience compare to CareCloud?

Do analysts recommend AIFF or CCLD?

Does the media favor AIFF or CCLD?

Do insiders and institutionals have more ownership in AIFF or CCLD?

Which has more volatility & risk, AIFF or CCLD?

Is AIFF or CCLD more profitable?

Which has better earnings and valuation, AIFF or CCLD?

Summary

How does Firefly Neuroscience compare to Teads?

Does the media prefer TEAD or AIFF?

Which has more volatility & risk, TEAD or AIFF?

Which has higher earnings and valuation, TEAD or AIFF?

Do institutionals & insiders hold more shares of TEAD or AIFF?

Do analysts recommend TEAD or AIFF?

Is TEAD or AIFF more profitable?

Summary

How does Firefly Neuroscience compare to Audioeye?

Do analysts recommend AIFF or AEYE?

Do insiders & institutionals hold more shares of AIFF or AEYE?

Is AIFF or AEYE more profitable?

Does the media prefer AIFF or AEYE?

Which has more volatility and risk, AIFF or AEYE?

Which has stronger earnings and valuation, AIFF or AEYE?

Summary

How does Firefly Neuroscience compare to Definitive Healthcare?

Which has preferable earnings & valuation, AIFF or DH?

Does the media favor AIFF or DH?

Which has more risk and volatility, AIFF or DH?

Is AIFF or DH more profitable?

Do institutionals & insiders hold more shares of AIFF or DH?

Do analysts recommend AIFF or DH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIFF vs. The Competition

Firefly Neuroscience Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools